Sign In
Get Clay Free →

Suggestions

    Paul McDonagh

    Chief Scientific Officer and Founder

    Paul McDonagh is a highly educated and experienced professional with a diverse background in both entrepreneurship and science.

    He holds a Certificate in Entrepreneurship/Entrepreneurial Studies from The Wharton School, a Certificate in C++ programming, and a Certificate in C Programming from the University of Washington. Additionally, he pursued a Ph.D. in Biochemistry and Protein structure at the University of Leicester, along with a B.Sc in Biological Science from the same institution.

    Throughout his career, Paul McDonagh has held various significant roles in prestigious organizations. He was the Chief Scientific Officer and Founder of Archetype Therapeutics, Inc., Owner and Principal at Birddog Genome Strategies, SVP & Chief Data Officer at Fulcrum Therapeutics, Vice President at Sema4, Senior Director at Alexion Pharmaceuticals, Inc., and also held positions at Biogen Idec, GNS Healthcare, Gene Network Sciences, Amgen, and Rosetta Inpharmatics.

    His experience ranges from Director positions in computational biology, discovery biology, to being an Associate Director and Principal Scientist in renowned pharmaceutical and healthcare companies.

    Paul McDonagh's career trajectory includes internships at leading companies like Astra Zeneca and Biocon Ltd, showcasing his dedication to gaining diverse experiences in the field.

    With a wealth of knowledge in biochemistry, protein structure, data science, informatics, and strategic alliances in the pharmaceutical industry, Paul McDonagh has established himself as a respected professional in the field of science and entrepreneurship.

    Highlights

    Jun 20 · Bio-IT World
    Alexion's Quest To Test The Algorithm Of Rare Disease Diagnosis - Bio-IT World
    P
    Add to my network

    Location

    Cambridge, Massachusetts, United States